| ABBVAbbVie Inc. | 185,761 | $40.4M |
| MRKMerck & Co., Inc. | 293,491 | $35.3M |
| GILDGILEAD SCIENCES, INC. | 247,719 | $34.5M |
| LLYELI LILLY & Co | 35,460 | $32.6M |
| JNJJOHNSON & JOHNSON | 113,380 | $27.7M |
| PFEPFIZER INC | 657,881 | $18.5M |
| AMGNAMGEN INC | 46,275 | $16.3M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 60,022 | $16.2M |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 34,991 | $15.6M |
| CAHCardinal Health Inc. | 68,898 | $14.6M |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 37,025 | $12.3M |
| REGNREGENERON PHARMACEUTICALS, INC. | 14,975 | $11.6M |
| BMYBRISTOL MYERS SQUIBB CO | 102,571 | $6.2M |
| GMOptec International, Inc. | 76,027 | $5.7M |
| INCYIncyte Corp. | 52,607 | $5.0M |
| SRRKScholar Rock Holding Corp | 98,700 | $4.9M |
| IONSIONIS PHARMACEUTICALS INC | 54,269 | $4.1M |
| IDYAIDEAYA Biosciences, Inc. | 122,064 | $4.1M |
| CORCencora Inc. | 11,236 | $3.5M |
| BIIBBIOGEN INC. | 15,973 | $2.9M |
| PGNYProgyny Inc. | 170,076 | $2.9M |
| ARWRARROWHEAD PHARMACEUTICALS, INC. | 44,045 | $2.8M |
| ABTABBOTT LABORATORIES | 25,143 | $2.6M |
| RAREUltragenyx Pharmaceutical Inc. | 99,995 | $2.1M |
| OLMAOlema Pharmaceuticals, Inc. | 116,812 | $1.7M |
| HALOHALOZYME THERAPEUTICS, INC. | 25,853 | $1.7M |
| NBIXNEUROCRINE BIOSCIENCES INC | 12,643 | $1.7M |
| BMRNBIOMARIN PHARMACEUTICAL INC | 26,288 | $1.5M |
| VKTXViking Therapeutics, Inc. | 43,984 | $1.4M |
| VRDNViridian Therapeutics, Inc.\DE | 69,530 | $1.4M |
| OSCROscar Health Inc. | 113,081 | $1.3M |
| RVMDREVOLUTION MEDICINES, INC. | 9,031 | $878K |
| BMEABiomea Fusion, Inc. | 557,036 | $852K |
| ZTSZoetis Inc. | 5,714 | $675K |
| RPRXRoyalty Pharma plc | 9,158 | $439K |
| DVADaVita Inc. | 1,505 | $231K |
| GEHCGE HealthCare Technologies Inc. | 828 | $59K |
| SDGRSchrodinger, Inc. | 2,000 | $23K |
| TEVATeva Pharmaceutical Industries Limited | 300 | $9K |
| APLSApellis Pharmaceuticals, Inc. | 4 | $161 |
| BHVNBiohaven Ltd. | 5 | $42 |
| BCYCBICYCLE THERAPEUTICS PLC | 9 | $42 |